Sikhulile Moyo
Research Associates

Sikhulile Moyo

Research Associate

Immunology and Infectious Diseases

smoyo@hsph.harvard.edu


Bibliography

Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study - final study results.

Makhema J, Shava E, Izu A, Gaolathe T, Kuate L, Walker A, Carty L, Georgiou P, Kgathi C, Choga WT, Sekoto T, Seonyatseng N, Mogashoa T, Maphorisa CN, Mohammed T, Ntalabgwe T, Frank TT, Matlhaku B, Diphoko A, Phindela T, Kaunda A, Kgari P, Kanyakula T, Palalani G, Phakedi I, Mmalane M, Taylor S, Moyo S.

IJID Reg. 2024 Mar. 10:35-43. PMID: 38090729


News

New tools for preventing the next pandemic

Technologies such as genomic sequencing have proved to be invaluable in responding to the COVID-19 pandemic and will be important in preventing future infectious disease outbreaks, according to the panel of experts who spoke at a Harvard T.H.…

The power of global partnerships in public health

Harvard T.H. Chan School of Public Health's Convocation for the Class of 2022—the first in-person graduation to be held since 2019 due to the COVID-19 pandemic—celebrated the accomplishments of 633 graduates.